Tectonic Therapeutic (TECX) News
NASDAQ: TECXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
20.73-0.31 (-1.47%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TECX news summary
We found 2 recent headlines mentioning Tectonic Therapeutic (TECX): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, TECX is down 1.47% at $20.73. The most recent story, "Tectonic Therapeutic to Participate in Upcoming Investor Conferences", was published by GlobeNewswire on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Tectonic Therapeutic headlines
- Tectonic Therapeutic to Participate in Upcoming Investor ConferencesWATERTOWN, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of…GlobeNewswire
- Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business HighlightsWATERTOWN, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic” or the “Company”), a clinical-stage biotechnology company focused on the discovery and…GlobeNewswire